VIVO Cannabis (TSXV: VIVO) (OTCQX: VVCIF) - Investor Dashboard

➔ VIVO Cannabis
Market Focus: Canada
Classification: Vertically Integrated
Country: Canada
Employees: 133 at 12/31/18
Established: 2012
CEO: Barry Fishman


Fiscal Year-End: December
Facilities: 3
Dried Flower: Production and Sale
Extracts: Production and Sale
Number of Patients: N/A
Headquarters: Napanee, Ontario

Financials (09/30/19)

Cash on hand: $50.1 million
Fixed Investment: $41.1 million
Shareholders’ Equity: $206.5 million
Revenues – Last Quarter: $6.3 million
Adj. Gross Margin : 25.3%
EPS : -0.03

Capital Structure (11/13/18)

Last Financing: 11.5 million Units at $3.50
Basic Shares: 295.8 million
Warrants: 15.2 million
Options: 9.9 million
Diluted Shares: 333.4 million

Company Brief

VIVO Cannabis Inc (TSXV: VIVO) (OTCQX: VVCIF) is a vertically integrated cannabis business focused on providing products and services that help people live better lives. VIVO participates in both the medical and adult-use markets with premium brands tailored to specific consumer segments and needs including Beacon Medical, Harvest Medicine, Lumina, Fireside, and Canna Farms. VIVO has 100% ownership of Canna FarmsTM – BC’s first and highly acclaimed licensed cannabis producer.  Together, Canna Farms and Harvest Medicine, one of Canada’s fastest growing medical cannabis clinics, are a fully integrated seed-to-sale solution.

With a commitment to quality and innovation – and a strong cash position – VIVO is well-positioned to be a respected cannabis company in Canada and select international markets.

Featured Video




  • Focus on pharmaceutical grade plant standardization
  • 94.7% customer retention rate
  • Organic production using exclusive, computer-controlled environmental system
  • Annual funded capacity of 57,000 kilograms by mid-2020
  • Experience developing novel product formats with dose-control and bioavailability
  • Brand porfolio focused on health and wellness: Canna Farms, Fireside, Lumina, Beacon Medical, and Harvest Medicine
  • Five clinics in Alberta, Ontario, Nova Scotia, and New Brunswick

Growth Strategy

  • Expand existing facility and constructing a second facility targeting 40-kilogram per annum production capacity
  • International market focus on Europe (approval to sell in Germany targeted in Q1 2020) and Australia
  • Active discussions to license production to U.S. operators
  • Scale up Harvest Medicine platform
  • 100% acquired licensed producer Canna Farms in British Columbia
  • Telemedicine offering developed by Harvest Medicine
  • Strategic partnerships with access to pharma networks
  • Retail partnerships with 50 distribution points and growing
  • Sponsorships including the Toronto Festival of Beer


  • Production through computer-controlled environmental systems
  • Industry-leading efficiency in terms of yield per square foot
  • Research partnerships with University of Guelph, Pharmascience, Loyalist College, and Think Research
  • Investment and supply agreement with the Choom brand
  • Supply agreements with Alberta, Ontario, British Columbia, Manitoba, Saskatchewan, and Yukon
  • Retail partnerships with Choom, Westleaf, National Access Cannabis, and Friendly Stranger
  • Canna Farms online shopping platform with more than 40 cannabis strains and 100 SKUs
  • Proprietary date from 50,000+ patients

Strong Advisory Board Led by
the “Father of Cannabis Medicine”

Raphael-Mechoulam-ABcannDr. Raphael Mechoulam is an Israeli organic chemist and professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel. Mechoulam is best known for his work (together with Y. Gaoni) in the isolation, structure elucidation and total synthesis of Δ9-tetrahydrocannabinol, the main active principle of cannabis and for the isolation and the identification of the endogenous cannabinoids anandamide from the brain and 2-arachidonoyl glycerol (2-AG) from peripheral organs together with his students, postdocs and collaborators.

Institutional Analyst Coverage

Mackie Research

Curated Stories & News

Visit VIVO Cannabis Inc (Formerly known as ABcann Global, Inc.)

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. VIVO Cannabis Inc (Formerly known as ABcann Global, Inc.) is a client of NCV Media, LLC. Read our full disclaimer.